Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

New methods for determining comparative effectiveness in rheumatoid arthritis.

Yun H, Curtis JR.

Curr Opin Rheumatol. 2013 May;25(3):325-33. doi: 10.1097/BOR.0b013e32835fd8c0. Review.

PMID:
23508131
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.

Oderda GM, Balfe LM.

J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl B):S19-24.

PMID:
22073936
[PubMed - indexed for MEDLINE]
Free Article
3.

Indirect and mixed treatment comparisons in arthritis research.

Ades AE, Madan J, Welton NJ.

Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv5-9. doi: 10.1093/rheumatology/ker241. Review.

PMID:
21859707
[PubMed - indexed for MEDLINE]
Free Article
4.

Comparative effectiveness of rheumatoid arthritis therapies.

Finckh A.

Curr Rheumatol Rep. 2010 Oct;12(5):348-54. doi: 10.1007/s11926-010-0123-0.

PMID:
20652775
[PubMed - indexed for MEDLINE]
5.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

PMID:
17049139
[PubMed - indexed for MEDLINE]
Free Article
6.

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Clark W, Jobanputra P, Barton P, Burls A.

Health Technol Assess. 2004 May;8(18):iii-iv, ix-x, 1-105. Review.

PMID:
15130461
[PubMed - indexed for MEDLINE]
Free Article
7.

Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?

Levesque MC.

BioDrugs. 2012 Apr 1;26(2):65-70. doi: 10.2165/11631320-000000000-00000.

PMID:
22385403
[PubMed - indexed for MEDLINE]
8.

The methods of comparative effectiveness research.

Sox HC, Goodman SN.

Annu Rev Public Health. 2012 Apr;33:425-45. doi: 10.1146/annurev-publhealth-031811-124610. Epub 2012 Jan 3. Review.

PMID:
22224891
[PubMed - indexed for MEDLINE]
9.

Some methodological points to consider when performing systematic reviews in comparative effectiveness research.

Berlin JA, Cepeda MS.

Clin Trials. 2012 Feb;9(1):27-34. doi: 10.1177/1740774511427062. Epub 2011 Nov 2.

PMID:
22049086
[PubMed - indexed for MEDLINE]
10.

Methods in comparative effectiveness research.

Armstrong K.

J Clin Oncol. 2012 Dec 1;30(34):4208-14. doi: 10.1200/JCO.2012.42.2659. Epub 2012 Oct 15. Review.

PMID:
23071240
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.

Colditz GA.

Crit Rev Food Sci Nutr. 2010;50 Suppl 1:10-2. doi: 10.1080/10408398.2010.526838.

PMID:
21132580
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.

Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.

PMID:
18405470
[PubMed - indexed for MEDLINE]
Free Article
13.

Comparative effectiveness of current treatments for rheumatoid arthritis.

Gibofsky A.

Am J Manag Care. 2012 Dec;18(13 Suppl):S303-14.

PMID:
23327518
[PubMed - indexed for MEDLINE]
Free Article
14.

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.

Barton P, Jobanputra P, Wilson J, Bryan S, Burls A.

Health Technol Assess. 2004 Mar;8(11):iii, 1-91. Review.

PMID:
14982655
[PubMed - indexed for MEDLINE]
Free Article
15.

The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.

Chalkidou K, Tunis S, Whicher D, Fowler R, Zwarenstein M.

Clin Trials. 2012 Aug;9(4):436-46. doi: 10.1177/1740774512450097. Epub 2012 Jul 2.

PMID:
22752634
[PubMed - indexed for MEDLINE]
16.

Anakinra for rheumatoid arthritis.

Mertens M, Singh JA.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005121. doi: 10.1002/14651858.CD005121.pub3. Review.

PMID:
19160248
[PubMed - indexed for MEDLINE]
17.

Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials.

Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F, Stoyanova-Scholz M, Wassenberg S, Kapelle A, Listing J.

Arthritis Rheum. 2006 Nov;54(11):3399-407.

PMID:
17075823
[PubMed - indexed for MEDLINE]
Free Article
18.

Evidence gaps in advanced cancer care: community-based clinicians' perspectives and priorities for CER.

Lowry SJ, Loggers ET, Bowles EJ, Wagner EH.

Am J Manag Care. 2012 May;18(5 Spec No. 2):SP77-83.

PMID:
22693985
[PubMed - indexed for MEDLINE]
Free Article
19.

Can observational studies replace or complement experiment?

van der Linden S, Goldsmith CH, Woodcock J, Nassonova V.

J Rheumatol Suppl. 1994 Sep;41:57-61.

PMID:
7799388
[PubMed - indexed for MEDLINE]
20.

Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach.

Devine EB, Alfonso-Cristancho R, Sullivan SD.

Pharmacotherapy. 2011 Jan;31(1):39-51. doi: 10.1592/phco.31.1.39.

PMID:
21182357
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk